1Department of Trauma and Surgical Critical Care, Pusan National University Hospital, Busan, Korea
2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
3Department of Emergency Medicine, Pusan National University School of Medicine, Yangsan, Korea
4Department of Diagnostic Radiology, The Catholic University of Korea Eunpyeong St. Mary's Hospital, Seoul, Korea
5Department of Trauma Surgery, Seoul National University Hospital, Seoul, Korea
6Department of Emergency Medicine, Pusan National University Hospital, Busan, Korea
© 2022 The Korean Society of Traumatology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ethical statement
This study was approved by the Institutional Review Board of the Pusan National University Hospital, Busan (No. H-2012-022-098).
Conflicts of interest
Hohyun Kim and Chan Yong Park serve on the Editorial Board of Journal of Trauma and Injury, but were not involved in the peer reviewer selection, evaluation, or decision process of this article. The authors have no other conflicts of interest to declare.
Funding
This work was supported by a clinical research grant from Pusan National University Hospital in 2021.
Author contributions
Conceptualization: RDY, KHH; Data curation: RDY; Formal analysis: KHH; Investigation: RDY; Methodology: LGH, JCH, KHH; Project administration: RDY, KHH; Resources: LGH, KHH; Supervision: KJH, YSR; Validation: KHH, KJH; Visualization: JCH; Writing–original draft: LGH; Writing–review & editing: KHH, PCY, YSR.
All authors read and approved the final copy of the manuscript.
Variable | Z-score | Estimate (SE) | OR (95% CI) | P-value |
---|---|---|---|---|
SSTLI | 5.84 | 0.027 (0.005) | 1.027 (1.018–1.036) | <0.001 |
Measure | Point | |||
---|---|---|---|---|
0 | 1 | 2 | 3 | |
Age (yr) | <60 | ≥60 | - | - |
Injury Severity Score | <25 | ≥25 | - | - |
Serum total bilirubin (mg/dL) | <1 | 1–2 | 2–3 | >3 |
Prothrombin time (INR) | <1 | 1–1.7 | 1.7–2.3 | >2.3 |
Serum creatinine (mg/dL) | <1 | 1–2 | 2–3 | >3 |
Characteristics | Survivor group (n=491) | Nonsurvivor group (n=30) | Total (n=521) | P-value |
---|---|---|---|---|
Age (yr) | 49 (33–60) | 56 (47–67) | 50 (33–61) | 0.037 |
Age group (yr) | 0.048 | |||
<60 | 360 (73.3) | 17 (56.7) | 277 (72.4) | |
≥60 | 131 (26.7) | 13 (43.3) | 144 (27.6) | |
Sex (male:female) | 360:131 | 22:8 | 382:139 | 0.999 |
ISS | 22 (17–29) | 29 (25–41) | 22 (4–50) | <0.001 |
ISS group | <0.001 | |||
<25 | 284 (57.8) | 7 (23.3) | 281 (55.9) | |
≥25 | 207 (42.2) | 23 (76.7) | 230 (44.1) | |
Operation | 0.002 | |||
NOM | 426 (86.8) | 20 (66.7) | 446 (85.6) | |
OM | 65 (13.2) | 10 (33.3) | 75 (14.4) | |
Angiography | 153 (31.2) | 12 (40.0) | 165 (31.7) | 0.312 |
Total bilirubin (mg/dL) | ||||
PTD 0 | 0.6 (0.4–0.9) | 0.6 (0.4–0.9) | 0.6 (0.4–0.9) | 0.972 |
PTD 1 | 0.9 (0.6–1.2) | 0.9 (0.6–1.5) | 0.9 (0.5–1.2) | 0.482 |
PTD 3 | 0.9 (0.6–1.4) | 1.7 (0.9–3.5) | 1.0 (0.7–1.5) | <0.001 |
PTD 5 | 1.3 (0.8–2.1) | 3.1 (1.5–7.2) | 1.3 (0.8–2.3) | <0.001 |
Prothrombin time (INR) | ||||
PTD 0 | 1.1 (1.0–1.2) | 1.2 (1.2–1.4) | 1.1 (1.0–1.2) | <0.001 |
PTD 1 | 1.2 (1.1–1.3) | 1.3 (1.3–1.5) | 1.2 (1.1–1.3) | <0.001 |
PTD 3 | 1.2 (1.1–1.3) | 1.4 (1.2–1.7) | 1.2 (1.1–1.3) | <0.001 |
PTD 5 | 1.2 (1.1–1.3) | 1.3 (1.2–1.5) | 1.2 (1.1–1.3) | <0.001 |
Creatinine (mg/dL) | ||||
PTD 0 | 0.9 (0.7–1.1) | 1.1 (0.9–1.3) | 0.9 (0.7–1.1) | <0.001 |
PTD 1 | 0.8 (0.6–0.9) | 1.3 (0.9–1.7) | 0.8 (0.6–1.0) | <0.001 |
PTD 3 | 0.6 (0.5–0.8) | 1.3 (0.9–1.8) | 0.7 (0.5–0.8) | <0.001 |
PTD 5 | 0.6 (0.5–0.8) | 1.3 (0.7–1.5) | 0.6 (0.5–0.8) | <0.001 |
SSTLI | Survivor group | Nonsurvivor group | P-value |
---|---|---|---|
Overall (n=521) | 491 | 30 | |
PTD 0 | 2 (1−3) | 3 (2–4) | <0.001 |
PTD 1 | 3 (2–3) | 4 (3–4.5) | <0.001 |
PTD 3 | 3 (2−4) | 5 (4–6) | <0.001 |
PTD 5 | 2 (3.5−5) | 6 (5−6) | <0.001 |
NOM group (n=446) | 426 | 20 | |
PTD 0 | 2 (1−3) | 3 (2−4) | <0.001 |
PTD 1 | 2 (2−3) | 4 (3−5) | <0.001 |
PTD 3 | 3 (2−3) | 4 (4−5) | <0.001 |
PTD 5 | 3 (3−5) | 5 (5−6) | <0.001 |
OM group (n=75) | 65 | 10 | |
PTD 0 | 2 (2−3) | 3.5 (3−4) | 0.010 |
PTD 1 | 3 (2−4) | 4 (4−4) | 0.028 |
PTD 3 | 3 (2−4) | 6 (4−7) | 0.011 |
PTD 5 | 4 (2−5) | 6 (6−7) | 0.006 |
Score | Probability of mortality (%) | Average | |||
---|---|---|---|---|---|
PTD 0 | PTD 1 | PTD 3 | PTD 5 | ||
0 | 0 | 0 | - | 0 | 0 |
1 | 1.7 | 0 | 0 | 0 | 0.4 |
2 | 4.1 | 2.4 | 4.9 | 7.1 | 4.6 |
3 | 7.8 | 7.1 | 5.0 | 5.3 | 6.3 |
4 | 17.0 | 18.5 | 23.3 | 6.7 | 16.4 |
5 | 15.4 | 14.8 | 33.3 | 20.0 | 20.9 |
6 | 20.0 | 40.0 | 50.0 | 53.9 | 41.0 |
7 | - | 50.0 | 100.0 | 50.0 | 66.7 |
8 | - | - | 33.3 | 100.0 | 66.7 |
9 | - | - | 100.0 | - | 100.0 |
PTD | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Correctly classified (%) | Prevalence (%) |
---|---|---|---|---|---|---|
0 | 10.0 | 96.9 | 16.7 | 94.6 | 91.9 | 5.8 |
1 | 25.0 | 92.8 | 23.1 | 93.5 | 87.4 | 7.9 |
3 | 52.2 | 90.8 | 50.0 | 91.5 | 85.0 | 15.0 |
5 | 83.3 | 68.4 | 38.5 | 94.5 | 71.3 | 19.1 |
Variable | Z-score | Estimate (SE) | OR (95% CI) | P-value |
---|---|---|---|---|
SSTLI | 5.84 | 0.027 (0.005) | 1.027 (1.018–1.036) | <0.001 |
INR, international normalized ratio.
Values are presented as median (interquartile range) or number (%). ISS, Injury Severity Score; NOM, nonoperative management; OM, operative management; INR, international normalized ratio; PTD, post-traumatic day.
Values are presented as number or median (interquartile range). SSTLI, scoring system for traumatic liver injury; PTD, post-traumatic day; NOM, nonoperative management; OM, operative management.
SSTLI, scoring system for traumatic liver injury; PTD, post-traumatic day.
SSTLI, scoring system for traumatic liver injury; PTD, post-traumatic day; PPV, positive predictive value; NPV, negative predictive value.
SE, standard error; OR, odds ratio; CI, confidence interval; SSTLI, scoring system for traumatic liver injury.